HLF

HERBALIFE LTD

Consumer Defensive | Small Cap

$0.75

EPS Forecast

$1,324

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Herbalife Q2 2024: EBITDA That Tells a Different Story Than Net Sales

Overview and the numbers that matter

Herbalife Ltd. (NYSE: HLF) reported its second-quarter 2024 results, with visible lines on the page that look like a classic: GAAP net income of $4.7 million and EPS of $0.05, alongside a far more expansive narrative in the non-GAAP space: adjusted net income of $54.8 million and adjusted diluted EPS of $0.54. The company also flagged net sales of about $1.3 billion, a 2.5% decline versus Q2 2023 driven by 270 basis points of foreign exchange headwinds, even as constant-currency growth in several regions flirted with stability. In other words, the raw sales line moved down, but the operating engine showed signs of life if you squint at the right metrics.

  • Revenue forecast (net sales): $1.3 billion, down 2.5% vs Q2’23 due to FX headwinds
  • Constant-currency net sales growth: up 0.2% year over year, led by Latin America, EMEA and Asia Pacific
  • EPS (GAAP): $0.05 per share; adjusted EPS: $0.54
  • Adjusted EBITDA: $180.0 million, exceeding guidance; EBITDA margin up about 120 basis points YoY

Non-GAAP discipline and the headwinds buried in the footnotes

As with Herbalife disclosures, much of the interesting plot lives in non-GAAP figures. Restructuring expenses, net of tax, and a modest debt-extinguishment headwind are explicitly carved out from adjusted results. Management argues these adjustments clarify the underlying operating trajectory, but the market gets a different flavor from the same dish when you compare GAAP to non-GAAP outcomes.

Specifics to note: restructuring expenses, net of tax reduce diluted GAAP EPS by about $0.33, and a $0.07 headwind from debt extinguishment is similarly excluded from adjusted metrics. In short, the company is telling you what the business would look like if you pretend some legacy costs never happened—and investors often take that as a cue about what management believes is the “real” trend.

Voice from the leadership

“Our Q2 Adjusted EBITDA is the highest it’s been in seven quarters. We remain focused on driving shareholder value as the continued increase in new distributors builds the foundation for sales growth.”

— Michael Johnson, Chairman and CEO

Cash, leverage, and capital allocation tempo

Operating cash flow stood at $102.5 million, with capital expenditures around $36 million. On the debt side, Herbalife cites a Credit Agreement EBITDA of $208.0 million and a total leverage ratio pressed down to 3.5x as of June 30. The company also completed a sale and sixteen-month leaseback of its Torrance, California office building in July, a move that net-net looks like balance-sheet optimization rather than a strategic bet on real estate exposure.

Outlook and guidance: a pivot, not a landslide

In the outlook, Herbalife provides third-quarter 2024 guidance and revises full-year 2024 guidance: net sales (revenue forecast) reduced, but adjusted EBITDA raised, and capital expenditures reaffirmed. The company emphasizes ongoing discipline in capital allocation, signaling a preference for leaner capex against the backdrop of FX volatility and a still-choppy consumer environment.

Implications for Herbalife and sector peers

The quarter spotlights a familiar tension in global consumer franchises: you can have a shaky reported top line due to currency moves while still producing robust cash generation and improving margins through operational discipline. Herbalife’s 3.5x leverage after June 30 suggests a roomier runway for deleveraging, asset sales, or selective buybacks if the organic growth engine stutters in the back half.

Analysts and industry peers will likely watch whether the distributor-driven growth narrative can sustain itself in an environment of FX noise and inflationary pressures. The strong adjusted EBITDA signal argues that the company remains capable of converting revenue volatility into cash flow, provided it can keep distributor activity expanding and limit the drag from non-operational costs.

From a market structure perspective, this release reinforces a broader pattern: companies lean on non-GAAP narratives to communicate operational strength while managing the balance sheet to preserve optionality. For peers in the MLM/consumer space, the lesson is clear—if you can show margin resilience and cash-flow generation even when reported net sales wobble, you keep your earnings story alive in an uncertain macro backdrop. The EPS trajectory—gaap and non-gaap—will be the most closely watched barometer for the sector’s next leg.

Conclusion: a profitable puzzle with a few missing pieces

Herbalife’s Q2 2024 reveals a bifurcated narrative: the GAAP numbers barely glitter, while the non-GAAP story glitters sufficiently to prompt a re-evaluation of earnings expectations. The currency headwinds are real, but the company’s operating leverage—driven by distributor activity and geographic mix—offers a path to sustained cash flow. The key tests ahead are whether the revenue forecast can stabilize or improve in the back half, whether EPS (both GAAP and adjusted) can surprise again on the upside, and if the balance-sheet discipline translates into meaningful de-leveraging without sacrificing growth initiatives.

For investors tracking EPS momentum, the revenue forecast and the earnings surprise potential in the coming quarters will be the core questions. In the near term, Herbalife’s focus on EBITDA generation and capital discipline suggests a prudent tilt toward value creation—an approach that, if sustained, could position the stock more as a cash-flow story than a mere sales story, with EPS consensus and guidance updates acting as the referee on an evolving financial playbook.